Epidemiology, being in many ways an exercise in various shades of grey, does not lend itself well to black or white questions such as: 'Are prospective studies worth while?' The problem is to determine how worth while they are and to define the situations in which a cross-sectional survey will be rewarding. It to answer this question but to present some of our own experiences in the Tecumseh study, in the hope of drawing some inferences from what are still preliminary results. Do data based on prevalence and incidence give essentially similar answers to certain epidemiological questions? Unfortunately, the data from the few prospective studies which have been in existence for an adequate time have not been analysed systematically from this point of view. There is a report, however, from Framingham which suggests that a relation between coronary heart disease and elevated blood pressure could have been established from prevalence data but that the well-known association with serum cholesterol levels, so evident from the incidence rates, would have been missed in terms of prevalence (Friedman et al. 1966) .
Turning now to the Tecumseh Community Health Study, it is recalled that about 90 % of the population of this town and surrounding area, comprising at that time some 9,500 persons, were examined in 1959 and 1960 (Francis & Epstein 1965 . Data on prevalence of cardiovascular disease and other disorders in Tecumseh and their relation to associated factors have been reported in considerable detail . Of the original cohort of some 8,600 persons, about 6,600 were re-examined. The majority of the approximately 2,000 persons not seen again in Round II either moved away or died; about 500 people refused participation. The data to be presented here refer only to coronary heart disease.
In calculating incidence rates, there was the problem that Round II took longer to complete than the tour de force accomplished in Round I. As a result, the interval between examinations varied among the participants (Table 1) . However, 92-1 % were re-examined within three to five years, and 64% within three-and-a-half to fourand-a-half years; the median interval was just short of four years. Although no allowance was Table I Frequency distribution of interval between examinations for persons examined in both Round I made for the variation in interval, these rates will therefore be referred to as 'four-year incidence'. The four-year incidence rates for coronary disease in the total population of men, for the age groups 20-39, 40-59 and 60 or over were: 1-4, 6-9 and 18-1 %, respectively. These rates, taking into account differences in diagnostic criteria, are in the general range shown by other studies . The same applies to the rates among women, being 1-8, 4 9 and 17-7 % over the average four-year period.
Criteria for the diagnosis of new events are shown in Table 2 . A history of myocardial infarction was never accepted as a sole criterion. Angina without Q-waves in the ECG accounted for half the diagnoses among men aged 40-59. New appearance of S-T and T-wave changes of a major degree accounted for almost a quarter of the diagnoses among men and for some 40% among women; complete heart block and complete left bundle branch block as new events were very rare. Twenty-six of the 60 men and 19 of the 79 women developed diagnostic Q-waves. Needless to say, lumping together of these manifestations into one category 'coronary heart disease' is undesirable; yet one is usually forced to do this on account of small numbers. The variability of electrocardiographic interpretation and of the diagnosis of angina will not be taken into account for the purpose of these analyses. A person diagnosed as having angina during Round I was excluded from the incidence cohort even though the diagnosis may not have been made again during Round II. It must be apparent that these diagnostic problems are at the very root of questions relating to one-time versus sequential observations. It is one 'secondary gain' to be derived from incidence studies that errors due to misclassification can be studied and assessed; it is interesting how little existing longitudinal data have been exploited from this point of view. It would not have been proper to present the preliminary data which follow without some discussion of the methods by which they were obtained and calculated, so that their tolerance can be weighed against whatever trends will emerge.
Part of the philosophy of the Tecumseh study has always been that the design should not be top-heavy and monolithic but allow for special studies within the study, among the so-called priority groups, to explore specific questions without necessarily involving the total population (Francis . One such priority group consists of the relatives of index cases with coronary disease and the relatives of matched control subjects, with additional matching for kindred size. The purpose is to see if the relatives of the index cases develop more coronary disease than those of the controls and, if so, to find the reason, whether it be genetic, environmental or both. Findings to date on male relatives are summarized in Table 3 . The denominators are regrettably small partly because one is of necessity limited to whatever prevalence cases are available at the outsetin this instance 209 men and womenand partly because we have studied so far only relatives in the Tecumseh area. Omitting the youngest age group where the expected incidence is low and the oldest group where the numbers are truly negligible, one sees a good deal of difference in incidence between relatives of index cases and controls in the 40-59 year age (Table 4) , it happens according to these figures that the phenomenon seen amoni men only in the middle age group is eviden among the younger and even the very few oldei relatives. In view of the small numbers, one would not even think at this stage to attempt a further breakdown by risk factors such as blooc pressure or serum cholesterol. Still, these charts are shown because the approach has mudh potenthi merit and illustrates a new use foi prospective observations. Unlike the index-case: control-kindred situation just shown, it has been possible to relate incidence to risk factors in the population at large. We were anxiously looking forward to these data because some of our findings based on prevalence were troublesome. We, like others, on the basis of prevalence failed to show a statistically significant relationship between coronary disease and serum cholesterol levels; similarly, there was no demonstrable association in Tecumseh between the prevalence of coronary disease and smoking habits . We were also looking forward to these data with excitement rather than anxiety because of the most interesting relationship which was demonstrated between glucose tolerance, not just diabetes, and the prevalence of coronary heart disease ). These and other relationships are summarized in terms of incidence in Tables 5 and 6. The five variables were divided into the highest, lowest and intermediate age and sex specific quintiles.
The number of men within each percentile range (Table 5 ), a r gradient is seen in the 40-59 age group for cholesterol and diastolic blood pressure but not for blood sugar. Once again, the incidence in the youngest and oldest age groups must be viewed guardedly, on account of the low incidence rates in the former and rather small denominators in the latter. No consistent trends are apparent for the other variables. Corresponding data for women are shown in Table 6 . Surprisingly, no gradient is seen for cholesterol, but blood pressure differentials are present in the younger and older age groups. Women in all three age groups have a higher incidence as the blood sugar increases, as was seen earlier in the prevalence data. Amongst women, as opposed to men, there appears to be an association for uric acid levels in the two younger age groups.
Conceivably, in these situations, a positive association may be obscured because persons lost from the cohort on account of death or otherwise are those who show particularly strong relationships between the disease and the risk factor in question. In this study, such a possibility has so far been tested only for those who died ( Table 7) . The category 'alive', refers to men who showed evidence of coronary heart disease at Round II but not at Round I and survived, in contrast to those who 'died of CHD'. With regard to serum cholesterol, there is certainly a suggestion beyond age 40 that men with elevated levels die preferentially of heart attacks as compared with those who survive with evidence of coronary heart disease. The same phenomenon is apparent for blood 261 153 57 sugar, so that the two opposing trends, that is, the incidence of nonfatal and fatal coronary heart disease in relation to these risk factors, seem to cancel each other out. In solving one problem, another has been created; if men with hyperglycemiaand there seems to be a similar tendency for womendie preferentially of heart attacks, how could it come about that the relation between glucose tolerance and coronary heart disease showed up so strongly in the Tecumseh prevalence data, considering that the incidence gradient among male survivors is, to say the least, negligible? Various limitations in the derivation of the present incidence rates must be recalled, as well as the rather polymorphous character of the ingredients within the total category 'coronary heart disease'. If one disregards these uncertainties and accepts the data at face value, one would have to say that, in a prevalence survey, there remains much to be learned about the kinds of people who do and who do not present themselves for examination at one moment of time. Considerable knowledge concerning this question could be obtained retrospectively through the use of data from prospective observations. From the point of view of prevalence and incidence, the Tecumseh data on smoking once again present a paradox (Table 8) ; the term 'alive' again refers to persons who developed coronary heart disease but survived. Comparing men who smoke cigarettes with nonsmokers, the incidence of both nonfatal and fatal disease is higher among the former within both age ranges. This being so makes it hard to understand why the prevalence data which were analysed exhaustively from every angle showed no vestige of a trend by smoking class . No rational explanation comes easily to mind. It is conceivable that the effect of smoking on coronary heart disease is more marked now than it was during earlier eras so that the composition of the cohort at the time of the prevalence study was determined by influences other than those which exerted their force during the incidence interval. Moreover, since coronary heart disease is the end-result of several competing risk factors, any analysis which considers only one factor at a time is undesirable and open to suspicion.
In the light of what has been said: are prospective studies really necessary? No doubt there are situations where nothing short of a prospective study will ever serve the purpose. For instance, one can only speak of a risk factor in the strict sense of the word if one can be reasonably certain that the factor in question has shown an abnormal value prior to the appearance of manifest disorder and that the abnormality is not the result of the disease itself. Moreover, by and large, one is on stronger ground as regards inferring a causal association between a risk factor and the disease if the association has been established on the basis of incidence rather than prevalence. No doubt, also, there are situations where observations on prevalence are adequate, particularly if there are no selective results of mortality or migration. There are now enough prospective studies which have prevalence information on the same people at several points of time to make systematic investigation of such selective factors possible and to define the situations in which prospective studies are not preferred. In the course of analysing data on such cohorts, one may further assess how much additional reliability and reproducibility may be gained from repeated, as opposed to one-time measurements, of diagnostic end-points and continuously distributed variables. The augury is good, it seems, to define the criteria upon which one can decide whether a given study should be prospective or crosssectional.
Professor D D Reid (London School of Hygiene and Tropical Medicine) said that both the opening speakers had made out good cases for the conduct of long-term prospective enquiries, particularly in chronic cardiovascular disease, but that it would be in keeping with the tradition of the Section to put the vital question quite bluntly. Prospective enquiries had almost become the sacred cow of epidemiology; the question was, did they earn their keep or could the same answers be obtained more cheaply and more quickly by one-shot cross-sectional or pointprevalence surveys ?
Professor Reid believed that they could agree with the speakers in two essential points immediately. Both had emphasized that in the precise delineation of the natural history or evolution of chronic cardiovascular disease, for example, there was no substitute for long-term study of the apparently well and the incipient case in the setting of the total population. It would also be agreed that it was important to recognize that the disease itself might alter associated risk characteristics. Change in blood pressure after infarction was an obvious example. Observer bias, especially in the psychiatric condition of patients recovering from infarction, was another obvious source of error in casecontrol studies which were in a sense only a special form of point-prevalence enquiry.
Recent experience both in Great Britain and in the United States suggested that the case fatality rate after episodes of cardiac ischaemia was greater among sedentary workers. Among the survivors, who were more likely to be actively employed, the point prevalence of angina or residual electrocardiographic changes was thus likely to be relatively higher than among sedentary workers from whom the most serious cases had been eliminated.
There was also a real danger of the pointprevalence study missing an important association between a factor such as smoking and serious ischvmic heart disease. In Dr Epstein's Tecumseh Study, as in the recent GPO Survey (Reid, Holland, Humerfelt & Rose 1966), the pointprevalence results showed no very obvious association between cigarette smoking and cardiovascular disorder. It could be that, here again, a working population was selected by the elimination of heavy smokers among whom sudden death without premonitory symptoms might be especially common.
There appeared to Professor Reid to be a suggestion in Dr Epstein's Table 7 that the success of prospective enquiries in detecting risk factors was that the end-point they used, for example sudden cardiovascular death or serious myocardial infarct causing admission to hospital, was a much more sensitive one than the relatively trivial criteria such as minor electrocardiographic changes used in point-prevalence studies. That might explain why there was very little disagreement among the various prospective studies in relation to severe myocardial infarct and death.
On the other hand, there was much less unanimity about, for example, the relation of smoking to angina which might be disabling but not quickly fatal. Here, larger numbers were required to detect the relatively small gradient in risk that might be involved, and the very complexity of long-term follow-up studies inevitably limited the number of subjects available for analysis. That limitation also meant that no very adequate adjustments could be made to take into account other relevant factors such as age, sex or employment. It was in these circumstances that a large-scale point-prevalence study might be especially helpful. In a recent survey (Reid, Cornfield, Markush, Seigel, Pedersen & Haenszel 
